NATIONAL BUREAU OF ECONOMIC RESEARCH
NATIONAL BUREAU OF ECONOMIC RESEARCH

Cost-Offsets of New Medications for Treatment of Schizophrenia

Richard G. Frank, Thomas G. McGuire, Sharon-Lise Normand

NBER Working Paper No. 12643
Issued in October 2006
NBER Program(s):   HC

Broad claims are frequently made that new medications will offset all or part of their costs by reducing other areas of Medicaid spending. In this paper we examine the net impact on spending for new drugs used to treat schizophrenia. We extend research in this area by taking a new approach to identification of spending impacts of new drugs. We specify and estimate models of spending on treatment of schizophrenia using 7 years of Florida Medicaid data. The estimates indicate that use of the new drugs result in net spending increases. This may be due to increased adherence to treatment.

download in pdf format
   (126 K)

email paper

The NBER Bulletin on Aging and Health provides summaries of publications like this.  You can sign up to receive the NBER Bulletin on Aging and Health by email.

This paper is available as PDF (126 K) or via email.

Machine-readable bibliographic record - MARC, RIS, BibTeX

Document Object Identifier (DOI): 10.3386/w12643

Users who downloaded this paper also downloaded these:
Shen w12374 The Effects of HMO and Its For-Profit Expansion on the Survival of Specialized Hospital Services
Monheit and Vistnes w12429 Health Insurance Enrollment Decisions: Preferences for Coverage, Worker Sorting, and Insurance Take Up
Sood, Buntin, and Escarce w12556 Does How Much and How You Pay Matter? Evidence from the Inpatient Rehabilitation Facility Prospective Payment System
Atack, Haines, and Margo w14410 Railroads and the Rise of the Factory: Evidence for the United States, 1850-70
Fraumeni w14736 The Contribution of Highways to GDP Growth
 
Publications
Activities
Meetings
NBER Videos
Data
People
About

Support
National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email: info@nber.org

Contact Us